Lewis T. Williams

Insider Reports History

Entity
Individual
Location
C/O Five Prime Therapeutics, Inc., Two Corporate Drive, South San Francisco, CA
Signature
/s/ Matthew Gosling, Attorney-in-Fact for Lewis T. "Rusty" Williams
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lewis T. Williams:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Arcellx, Inc. Director Common Stock 2.1M $116M $55.27 Feb 8, 2022 Indirect
Protagonist Therapeutics, Inc Director Stock Option (right to buy) 25.7K Jan 2, 2024 Direct
Neoleukin Therapeutics, Inc. Director Stock Option (Right to Buy) 25K May 11, 2021 Direct
Arcellx, Inc. Director Series B-1 Preferred Stock 0 Feb 8, 2022 Indirect
Arcellx, Inc. Director Series B-2 Preferred Stock 0 Feb 8, 2022 Indirect

Insider Reports Filed by Lewis T. Williams

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PTGX Protagonist Therapeutics, Inc Jan 2, 2024 1 $0 4 Jan 4, 2024 Director
PTGX Protagonist Therapeutics, Inc Jan 16, 2023 1 $0 4 Jan 18, 2023 Director
PTGX Protagonist Therapeutics, Inc May 26, 2022 1 $0 4 May 27, 2022 Director
ACLX Arcellx, Inc. Feb 8, 2022 3 $0 4 Feb 9, 2022 Director
ACLX Arcellx, Inc. Feb 3, 2022 0 $0 3 Feb 3, 2022 Director
PTGX Protagonist Therapeutics, Inc May 27, 2021 1 $0 4 May 28, 2021 Director
NLTX Neoleukin Therapeutics, Inc. May 11, 2021 1 $0 4 May 13, 2021 Director